Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y F Liaw

Showing results (1-10 of 346) with videos related to

Pageof 35
Sort By:
Alimentary Pharmacology & Therapeutics|February 5, 2016
Letter: nucleos(t)ide analogues are good, but not sufficient for hepatitis B virus clearance--author's replyY-F Liaw
Antiviral Chemistry & Chemotherapy|October 12, 2001
Impact of YMDD mutations during lamivudine therapy in patients with chronic hepatitis BY F Liaw
Hepatology (Baltimore, Md.)|June 1, 1990
Chronic hepatitis caused by the hepatitis A virusY F Liaw
Hepatology (Baltimore, Md.)|August 1, 1990
Diagnosis and onset of acute hepatitis delta virus infectionY F Liaw
Hepatology (Baltimore, Md.)|October 1, 1995
Role of hepatitis C virus in dual and triple hepatitis virus infectionY F Liaw
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 1, 1995
Acute exacerbation and superinfection in patients with chronic viral hepatitisY F Liaw
Lancet (London, England)|December 25, 1982
HBeAg/anti-HBe and alpha-fetoproteins levels in primary hepatocellular carcinomaY F Liaw
Gastroenterology|August 1, 1978
Outpatient liver biopsyY F Liaw
Gastroenterology|November 1, 1981
Steroids, Bridging necrosis in hepatitisY F Liaw
Journal of Gastroenterology and Hepatology|January 4, 1998
Current therapeutic trends in therapy for chronic viral hepatitisY F Liaw
Pageof 35

Showing results (1-10 of 346) with videos related to

Sort By:
Pageof 35
Alimentary Pharmacology & Therapeutics|February 5, 2016
Letter: nucleos(t)ide analogues are good, but not sufficient for hepatitis B virus clearance--author's replyY-F Liaw
Antiviral Chemistry & Chemotherapy|October 12, 2001
Impact of YMDD mutations during lamivudine therapy in patients with chronic hepatitis BY F Liaw
Hepatology (Baltimore, Md.)|June 1, 1990
Chronic hepatitis caused by the hepatitis A virusY F Liaw
Hepatology (Baltimore, Md.)|August 1, 1990
Diagnosis and onset of acute hepatitis delta virus infectionY F Liaw
Hepatology (Baltimore, Md.)|October 1, 1995
Role of hepatitis C virus in dual and triple hepatitis virus infectionY F Liaw
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 1, 1995
Acute exacerbation and superinfection in patients with chronic viral hepatitisY F Liaw
Lancet (London, England)|December 25, 1982
HBeAg/anti-HBe and alpha-fetoproteins levels in primary hepatocellular carcinomaY F Liaw
Gastroenterology|August 1, 1978
Outpatient liver biopsyY F Liaw
Gastroenterology|November 1, 1981
Steroids, Bridging necrosis in hepatitisY F Liaw
Journal of Gastroenterology and Hepatology|January 4, 1998
Current therapeutic trends in therapy for chronic viral hepatitisY F Liaw
Pageof 35